Pieter L. Jager

Indium-111–Labeled Trastuzumab Scintigraphy in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer

Patrick J. Perik, Marjolijn N. Lub–de Hooge, Jourik A. Gietema et al. · Journal of Clinical Oncology · 2006 · 307 citations · Full text

Selectivity of 18F-FLT and 18F-FDG for differentiating tumor from inflammation in a rodent model.

Aren van Waarde, D. Cobben, Albert J.H. Suurmeijer et al. · PubMed · 2004 · 267 citations

Improved Staging of Patients With Carcinoid and Islet Cell Tumors With ¹⁸F-Dihydroxy-Phenyl-Alanine and ¹¹C-5-Hydroxy-Tryptophan Positron Emission Tomography

Klaas Pieter Koopmans, Oliver Neels, Ido P. Kema et al. · Journal of Clinical Oncology · 2008 · 237 citations · Full text

Staging of carcinoid tumours with 18F-DOPA PET: a prospective, diagnostic accuracy study

Klaas Pieter Koopmans, Elisabeth G.E. de Vries, Ido P. Kema et al. · The Lancet Oncology · 2006 · 233 citations

Positron Emission Tomography, Health Sciences, Oncologic Imaging +10

Preclinical characterisation of ¹¹¹In‐DTPA‐trastuzumab

Marjolijn N. Lub‐de Hooge, Jos G. W. Kosterink, Patrick J. Perik et al. · British Journal of Pharmacology · 2004 · 176 citations · Full text